Crossmark

A New Analytical LC–MS/MS Method for Determination of Eight Standard Nitrosamines (NDMA, NMBA, NDEA, NEIPA, NDIPA, NMPA, NDPA, NDBA) in a Commercial Small Molecule Drug Product Capsules and its Active Pharmaeceutical Ingredient for Treatment of Fabry: A Rare Disease

Crossref DOI link: https://doi.org/10.1007/s11095-025-03875-7

Published Online: 2025-06-17

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Charagondla, Krishnaiah

Mukherjee, Partha S.

Ginjupalli, Kalyani

Hu, Bing

Kaur, Simrat

Thanki, Paresh

Tailor, Tejas

Prajapati, Bhavin

Ramdas, Saroj
License Information

Text and Data Mining valid from 2025-06-17

Version of Record valid from 2025-06-17
More Information

Article History

Received: 27 January 2025

Accepted: 17 May 2025

First Online: 17 June 2025

Declarations

:

: This research received no external financial or non-financial support.

: Krishnaiah Charagondla, Partha S. Mukherjee, Kalyani Ginjupalli, and Saroj Ramdas report relationships with Amicus Therapeutics that include employment and equity or stocks. Bing Hu, Simrat Kaur, Paresh Thanki, Tejas Tailor and Bhavin Prajapati with SGS Health Science North America-Canada.Patents and Intellectual Property. There are no patents to disclose.

: There are no additional activities to disclose.

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Document is current

Any future updates will be listed below